Only a subset of these regions were affected in both CD34+CD15− and CD34−CD15+ cells, indicating that DNA methylation could contribute to the clonal heterogeneity of the early CML phase. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.